List of articles with "Kazia Therapeutics"

Kazia's Cancer Breakthroughs

Kazia's Cancer Breakthroughs

Australia Sydney TNBC Kazia Therapeutics Immuno-Oncology
Kazia's FDA Meeting Plans

Kazia's FDA Meeting Plans

Australia Sydney Kazia Therapeutics Paxalisib GBM
Kazia's PD-L1 Collaboration

Kazia's PD-L1 Collaboration

Australia Sydney Cancer Immunotherapy Kazia Therapeutics PD-L1 Degrader
Kazia's Tumor Burden Triumph

Kazia's Tumor Burden Triumph

Australia Sydney TNBC Kazia Therapeutics Paxalisib
AI in Brain Cancer

AI in Brain Cancer

AI Technology Australia Sydney Kazia Therapeutics Paxalisib
Kazia Therapeutics Breakthrough

Kazia Therapeutics Breakthrough

Australia Sydney Kazia Therapeutics Paxalisib HER2-positive cancer
Kazia Secures $2M

Kazia Secures $2M

oncology Australia Sydney Private Placement Kazia Therapeutics
Kazia's Early Data Success

Kazia's Early Data Success

Australia Sydney Kazia Therapeutics Paxalisib Triple-Negative Breast Cancer
Paxalisib Breakthrough

Paxalisib Breakthrough

Australia Sydney TNBC Kazia Therapeutics Paxalisib
Kazia Starts Breast Cancer Trial

Kazia Starts Breast Cancer Trial

Australia Sydney Kazia Therapeutics Paxalisib Advanced Breast Cancer
Kazia's Progress Update

Kazia's Progress Update

Australia Sydney Kazia Therapeutics Paxalisib Parkinson's Research
Kazia Sells Cantrixil IP

Kazia Sells Cantrixil IP

Australia Sydney Kazia Therapeutics Vivesto Cantrixil
Kazia's New Parkinson's Research

Kazia's New Parkinson's Research

Australia Parkinson's Disease Sydney Kazia Therapeutics Paxalisib
Kazia's Advanced Cancer Trial

Kazia's Advanced Cancer Trial

Australia Kazia Therapeutics Paxalisib Queensland Triple Negative Breast Cancer
Kazia's $2M Direct Offering

Kazia's $2M Direct Offering

Cancer Research oncology Australia Sydney Kazia Therapeutics
Kazia Secures $2M Offering

Kazia Secures $2M Offering

oncology Australia Sydney Kazia Therapeutics Paxalisib
Kazia's Paxalisib Update

Kazia's Paxalisib Update

FDA Australia Sydney Kazia Therapeutics Paxalisib
Kazia Presents New Data

Kazia Presents New Data

Immunotherapy Australia Sydney Kazia Therapeutics Paxalisib

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.